Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues:
Premiums and other considerations	$ 7,664	$ 5,410
Annuity product charges	59,549	52,966
Net investment income	573,318	558,438
Change in fair value of derivatives	(941,874)	384,469
Net realized gains (losses) on investments, excluding credit losses on fixed maturity securities, available for sale	11,035	(563)
Credit losses on fixed maturity securities, available for sale	(31,371)	0
Loss on extinguishment of debt	(2,024)	0
Total revenues	(323,703)	1,000,720
Benefits and expenses:
Insurance policy benefits and change in future policy benefits	10,072	9,299
Interest sensitive and index product benefits	400,219	136,674
Amortization of deferred sales inducements	73,591	33,309
Change in fair value of embedded derivatives	(1,250,061)	766,323
Interest expense on notes payable	6,385	6,379
Interest expense on subordinated debentures	1,588	4,088
Amortization of deferred policy acquisition costs	120,702	45,132
Other operating costs and expenses	43,626	38,979
Total benefits and expenses	(593,878)	1,040,183
Income (loss) before income taxes	270,175	(39,463)
Income tax expense (benefit)	27,228	(9,453)
Net income (loss)	242,947	(30,010)
Less: Preferred stock dividends	6,611	0
Net income (loss) available to common stockholders	$ 236,336	$ (30,010)
Earnings (loss) per common share	$ 2.58	$ (0.33)
Earnings (loss) per common share - assuming dilution	$ 2.57	$ (0.33)
Weighted average common shares outstanding: earnings (loss) per common share	91,644,315	90,883,254
Weighted average common shares outstanding: earnings (loss) per common share - assuming dilution	92,021,079	91,743,759